Sometimes referred to as "bench to bedside" medicine, translational research "translates" those discoveries made in the research laboratory into a clinical setting so patients can benefit from the research quicker. Translational research is also referred to as translational medicine.

Abramson Cancer Center’s researchers are leaders in discoveries that advance science and pave the way for new therapies and procedures to improve human health. The basic and clinical research findings emerging from Penn’s laboratories and hospitals improve the treatment of a wide range of medical conditions and provide the foundation of knowledge on which many of medicine's next generation of cures will be developed.

The Institute for Translational Medicine and Therapeutics (ITMAT) at Penn supports research at the interface of basic and clinical research focusing on developing new and safer medicines. ITMAT laboratories are housed within the Smilow Center for Translational Research.

Philly Fights Cancer is proud to fundraise for translational research and clinical trials that make new treatments possible.

Learn more about the Institute for Translational Medicine and Therapeutics.

And learn more about Abramson Cancer Center’s current clinical trials here:

https://acc.careboxhealth.com/trials#trials